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Purpose: Diabetes represents one of the greatest health challenges facing the UK. Telehealth 
is seen to have the potential to revolutionize health care provision by improving access for 
patients with chronic disease, reducing health care costs, and improving efficiency. There 
have been many trials of telehealth in the UK but these have typically failed to become part 
of routine health care, particularly for diabetics. Program design and implementation has not 
been grounded in an understanding about the ways in which patients manage their disease and 
perceive these new technologies. This study addresses this gap by gaining an understanding 
of the perceptions of patients with type 1 diabetes about how telehealth could be used as part 
of their health care.
Patients and methods: Thirty-two people with type 1 diabetes were recruited from a database 
of insulin pump users, and in-depth telephone interviews were undertaken, tape recorded, and 
transcribed. Analysis was conducted using a constant comparative approach.
Results: Although respondents used technology as part of their diabetes self-management, 
they considered that the use of telehealth, as part of their health care, was potentially of limited 
value. Three themes emerged from their discourses: (1) a need to be in control of their disease 
themselves and a lack of trust of health care professionals in this process; (2) the belief that the 
National Health Service routine IT systems were unable to support telehealth; and (3) the belief 
that face-to-face communication was vital in providing them with high-quality care.
Conclusion: Telehealth is considered to be revolutionizing health care and shifting power 
between patients and health professionals; however, evidence of its effectiveness in delivering 
improved outcomes for diabetes is limited. The findings presented here suggest that there is a 
need to understand the context of patients’ self-management and their perceptions of their role 
in telehealth if it is to be successful.
Keywords: patient knowledge, telehealth, self-management, diabetes care, information 
technology
Introduction
Diabetes represents one of the biggest public health challenges facing the UK.1 It is 
estimated that 3.8 million people in the UK are living with diabetes and that the figure 
is expected to increase to 6.25 million by 2035/6.2 Diabetes is associated with serious 
complications including heart disease, stroke, blindness, kidney disease, nerve damage, 
and amputations, all of which lead to disability and premature mortality.1 Diabetes 
currently costs the National Health Service (NHS) approximately £9.8 billion for direct 
patient care (which includes treatment, interventions and management of complications) 
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and a further £13.9 billion for indirect costs, such as work 
loss and the need for informal care.2
In order to prevent the development of complications and 
reduce the number of deaths from diabetes, there is a need 
to increase awareness of the risks, bring about changes in 
lifestyle and self-management among people with diabetes, 
and to improve access to integrated diabetes services.1 As 
with many other chronic illnesses, there is a drive to shift 
some of the burden of routine diabetes management out of the 
formal health care system by developing patient knowledge 
and self-awareness through “expert patient” programs.3 This 
has been paralleled with an increase in the implementation 
of telehealth pilot projects to support patients in the manage-
ment of their diabetes.
Telehealth has been defined as the use of information, 
computing, and telecommunications technology to pro-
vide health related services, health promotion, and disease 
management across geographic, time, social, and cultural 
barriers.4 It involves providing health care at a distance 
using technical artifacts to mobilize representations of and 
information about patients.5
Telehealth interventions for type 1 and type 2 diabetes 
have incorporated the asynchronous (store and forward) 
transmission of patient data, mainly blood glucose measure-
ments, and treatment and diet or lifestyle advice by telephone 
or internet.6 Evidence of the effectiveness of telehealth 
interventions in improving glycemic control or in reducing 
health care costs, is however, limited.6–9 Although systematic 
reviews have confirmed the feasibility of remote monitoring 
and home telehealth for a range of disease categories and 
patient  populations, questions remain regarding its efficacy 
in long-term diabetes control.8,10
Gately et al11 argue that the successful introduction of 
technology to aid the management of long term conditions 
is viewed as a technological process, in which the user is 
assumed to be an active participant in its implementation, 
but that such assumptions are not necessarily grounded 
in an understanding about the ways in which patients 
may engage with, adapt to, and integrate new forms of 
 technology. The way in which telehealth providers respond 
to the demands and expectations that their patients place 
on remote care delivery systems, is critical to the future 
of remotely delivered health care.4 Consideration of the 
patient’s view or perceptions in relation to incorporating 
telehealth into their disease management, is particularly 
important in the case of people with diabetes as they 
spend only around 1% of their time in contact with health 
 professionals, and 99% of their time self-managing their 
disease within the constraints of their everyday lives.12 
Funnell and Anderson13 suggest that the serious and chronic 
nature of diabetes, the complexity of its management, and 
the multiple daily self-care decisions that people with dia-
betes must make, means that adherence to predetermined 
care programs may be difficult. Health care for patients 
with diabetes needs to be designed to fit patients’ priorities, 
goals, resources, lifestyle, beliefs and knowledge.13 These 
factors also have the potential to affect interaction with, 
and acceptance of, telehealth.
McLean et al14 argue that although patient’s attitudes to 
telehealth have been extensively studied, with most report-
ing patients seeing this as a positive development, caution 
is required when interpreting the findings. In particular, 
 studies are considered to lack depth, and there is an argument 
for using qualitative approaches, which can generate more 
rounded, nuanced understandings of patients’ experiences 
and expectations.14
Little in-depth, qualitative research has been conducted 
into the perceptions of diabetes patients about the use of 
telehealth in the management of their disease, and in their 
interactions with health professionals. This paper aims to 
address this gap by examining the perceptions of people with 
type 1 diabetes about the potential role of telehealth in the 
management of their disease, and in their interaction with 
health professionals.
Methods
The data presented in this paper are drawn from a larger study 
(Ruston et al, unpublished data, 2011) that aimed to gain an 
understanding of how diabetes self-management could be 
supported more effectively using telehealth.
Study design and sample
The study utilized a national database already housed in our 
University, of people with type 1 diabetes who use or have 
used continuous subcutaneous insulin infusion technology 
(insulin pump). The database was compiled from users of 
an online support organization, which advocates access to 
insulin pumps and other diabetes technologies in the UK 
(Wilson, unpublished data, 2008).
Insulin pumps continually infuse insulin into the subcu-
taneous tissue at a rate that is preset according to the type1 
diabetic patient’s needs, with patient activated boosts when 
food is eaten. The diabetic patient sets the insulin dose 
according to his or her diet, exercise, and blood glucose 






levels, and it is recommended that blood glucose is checked 
four times a day to obtain the information needed to set the 
appropriate insulin dose. Insulin pump technology has the 
functionality to electronically record, and share data with a 
health care professional. Recruitment continued until data 
saturation was reached.
A total of 32 diabetics were interviewed, including 20 
females and 12 males. Of these, 23 were currently using 
insulin pump therapy, and nine were using multiple daily 
injections having used an insulin pump in the past.
Data collection
Respondents were approached by telephone and their treat-
ment mode ascertained, the study was explained to them, and a 
suitable time agreed for interview. Telephone interviews were 
conducted due to the geographical spread of the sample. The 
interviews were semistructured and covered participants’ 
perceptions about the potential role of telehealth in the 
management of their disease, communication with health 
professionals using telehealth, who they considered to be 
responsible for the management of the disease, the barriers they 
encountered in self-management, factors that facilitated good 
management, and what could be done to support them.
The study gained University ethics approval for access 
to patients from the database. Verbal consent was obtained 
from respondents at the time of telephone interview.
Data analysis
The interviews, lasting between 30 and 40 minutes, were 
tape recorded and transcribed. Preliminary analysis was 
undertaken concurrently with data collection to identify 
emerging themes and ensure that sufficient respondents were 
recruited to achieve data saturation on all elements of the 
overall study. Initial analysis was conducted using a constant 
comparative approach.15 Each transcript was separately read 
by two members of the research team to identify emerging 
categories of data or themes. The transcripts were reread, and 
categories compared with one another to identify similarities 
and differences. The categories were then refined to ensure 
that the concepts, relations between variables, and differ-
ences between the themes could be confirmed or modified 
as necessary.
Results
The age, sex, mode of treatment, length of time since diag-
nosis, and occurrence of complications and hypoglycemic 
events of individual respondents are shown in Table 1. 
All respondents reported that they used IT as part of their 
everyday lives, and described using technology as part of 
their self-management of their diabetes. The majority (25) 
also reported downloading results to their computer to help 
them monitor or fine tune their diabetes management:
I use a pump combined with a Life Scan blood glucose 
meter and also software that comes with the Life Scan meter, 
which I then download into my computer, which gives me a 
good reference as to how I’m doing. … It is useful it enables 
me to fine tune the basal rates [levels of insulin delivery] on 
the pump to give me the best control. [Interview 3]
My blood machine does actually upload onto a  computer. 
I don’t like the software it came with and my husband has 
devised a system where we upload the information and then 
drag the blood sugars out of it and into a chart that makes 
more sense. [Interview 14]
Of the seven respondents that did not download data from 
their insulin pumps or blood glucose meters, three said they 
did not know how to use the technology to download results, 
and four said they did not have the motivation to do this.
When asked if they had heard of telehealth, most respon-
dents said they had not heard of the term but were able 
to describe activities which constituted telehealth. Three 
respondents described situations where they had engaged 
in telehealth as part of their health care. However, when 
asked about the value of using telehealth as part of their 
diabetes management, they considered it to have a number 
of limitations.
Three themes emerged from their discourses about 
 telehealth, and the management of their diabetes: (1) a need 
to be in control of their disease themselves and a lack of trust 
of others in this process; (2) the belief that the NHS routine IT 
systems were unable to support telehealth; and (3) the belief 
that face-to-face communication was vital in providing them 
with high quality care.
Self in control and lack of trust  
in others in this process
The average number of years that respondents had been living 
with diabetes was 29 and, as a consequence, they considered 
that they possessed their own, unique understanding of their 
diabetes. They considered themselves to be experts in the 
management of their own disease:
When I was a kid my diabetes ran like the book says, 
straightforward, but now all my levels start doing really 
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kooky things, and because of that I’ve sort of invented my 
own ways of dealing with it. [Interview 14]
I rely on “feelings” to manage my diabetes, and to decide 
whether to check my blood sugar. [Interview 32]
Rather than rely on my pump, I alter the insulin dose myself. I 
would rather alter it myself and I keep testing my blood – well 
I don’t think we are all the same. I don’t think our bodies use 
the insulin and the sugar at the same pace. [Interview 20]
This belief that they possessed a unique intelligence 
about their own disease was coupled with a lack of trust in 
the knowledge base of the health professionals who were 
there to support them:
My body acts differently to others’. Personally, I find that 
I’m the best person who knows what to do and there are 
only a few people I trust to help me manage and control my 
diabetes. [Interview 2]
I’ve been a diabetic for so long I know more about my 
diabetes than they [health professionals] will ever know. 
[Interview 5]
I feel that I manage my diabetes myself. …฀I don’t have a lot of 
trust in other people I prefer to control it myself. [Interview 1]
Respondents’ discourses revealed a general concern about 
whether certain health professionals, particularly those from 
primary care, had sufficient knowledge or expertise to deliver 
good quality diabetic care to patients with type 1 diabetes:
I’ve had appointments with GPs and they’ve never even 
seen an insulin pump let alone, you know, heard about it. 
Any they’ll say to me, “Well, I’m sorry. I really don’t know.” 
And with the condition of neuropathy [nerve damage caused 
by diabetes] that I have, if I then have to increase my pain 
relief, nobody understands the management of it. So I really 
try to make sure I have back up from my diabetes centre. 
[Interview 30]
Table 1 Sample characteristics
Respondent  
number




Length of time since  
diagnosis (years)




1 F 45 Injections type 1 17 no Yes
2 F 49 Pump type 1 38 no Yes
3 M 65 Pump type 1 21 Yes Yes
4 F 41 Pump type 1 31 Yes Yes
5 M 44 Injections type 1 40 Yes Yes
6 M 59 Injections type 1 36 no no
7 F 58 Pump type 1 26 no no
8 F 33 Pump type 1 21 no no
9 M 62 Pump type 1 16 Yes Yes
10 M 33 Injections type 1 21 no Yes
11 M 53 Pump type 1 26 Yes Yes
12 F 48 Pump type 1 37 no Yes
13 F 39 Pump type 1 31 Yes Yes
14 F 30 Pump type 1 29 Yes Yes
15 F 64 Pump type 1 42 Yes Yes
16 M 60 Injections type 1 30 no no
17 M 45 Pump type 1 21 Yes no
18 F 62 Injections type 1 15 no Yes
19 F 54 Injections type 1 22 Yes Yes
20 F 50 Pump type 1 26 no no
21 F 55 Pump type 1 20 no Yes
22 M 65 Pump type 1 64 Yes Yes
23 F 65 Pump type 1 40 no no
24 M 46 Pump type 1 43 Yes Yes
25 F 53 Pump type 1 50 Yes Yes
26 F 64 Pump type 1 13 no Yes
27 F 40 Pump type 1 26 no Yes
28 F 50 Pump type 1 20 no Yes
29 F 44 Pump type 1 31 Yes no
30 F 53 Pump type 1 22 Yes no
31 M 54 Injection type 1 40 Yes Yes
32 M 45 Injection type 1 30 no Yes






I wouldn’t ring the GP, I seem to know more about it than 
they do. I would always go to my diabetic consultant, or my 
diabetic pump team at the hospital. [Interview 22]
I certainly wouldn’t consider giving them [blood glucose 
results] to my GP as I don’t think he would understand them, 
but I might to my diabetes practice nurse. [Interview 2]
The nurse tends to ask the questions and I tend to advise 
her! [Interview 3]
Those respondents who were unable to gain support 
from their local NHS for their insulin pump reported having 
to rely on their own skills and having to obtain informa-
tion from the pump manufacturers, rather than their health 
professionals.
Routine nHS IT systems not compatible 
with their technology
Respondents reported that, although the technology they 
used to manage their diabetes had the potential to pro-
vide important information that could be used by health 
professionals, they were unable to utilize it due to system 
incompatibility:
Well certainly, when I was trialing the continual blood 
glucose monitor sensors, I was given a package so that 
we could download the information but the hospital 
network couldn’t cope with the system, so I ended up 
having to download it onto my own laptop, and physically 
taking it to the hospital so they could look at it …฀You 
would think that the fact that the hospital are purchas-
ing these Medtronic and Dissertronic pumps, that they 
should be able to cope with the IT set up. But they can’t. 
[Interview 30]
My insulin pump does keep a record of my sugar levels 
and if the hospital clinic had the software I could download 
them but they don’t have the software for my pump. 
[Interview 2]
The practice does not take email attachments so cannot send 
my results through, and my pump software is not compatible 
with their computer system. [Interview 5]
In addition to problems with compatibility, some respon-
dents also reported that where they had transformed their data 
to a format that was accessible, such as on a data stick or in 
hard copy format, there was no guarantee that it would be 
utilized. For example, the following respondent downloaded 
his results onto a data stick but it was not used because of 
the hospital policy around data security:
Well last time I went [to the clinic], I was very annoyed 
because this pump comes with the software to put your results 
on a memory stick and I had all this. I took it along to the 
 consultation. “Oh no, we can’t look at that! We’re not allowed 
to put anything like that on our computer” [they told me]. So 
I had to rely on what my own analysis of it was, rather than 
them looking at the actual figures. [Interview 24]
Another took their results in hard copy but found that it 
was still not looked at:
I download information from my meter to my PC and then 
print it out and take it to my 6 monthly review because they 
don’t have the software, but they don’t actually look at it. 
[Interview 6]
When discussing the use of telehealth to ask their 
health care team for support or information, respon-
dents felt that a shortage of staff time would preclude 
any meaningful feedback, if indeed they were to get any 
feedback:
I don’t see a problem with doing it [telehealth] but I’d like 
to know where they [NHS staff] are going to get the time 
to sit in front of a computer and read your results, and give 
you feedback. [Interview23]
I don’t think it would work [telehealth] because the 
kind of doctors and GPs and consultants I know, they’re 
not going to be ringing you back. They might have a 
thousand patients on their books. They can’t all be on the 
phone. [Interview 9]
When I first got my pump the nurse said, “I’ve got this man 
who continually sends me all his test results and it drives me 
mad!” And I thought if everybody was continually sending 
their results they’d never get anything done. [Interview 26]
Where respondents reported having access to support 
via the telephone or email, they felt it was of limited value 
because it was provided asynchronously rather than in 
real time:
I do have a telephone service for problems but it is not 
an instantaneous service. You have to leave a message 
and it could be two days before they get back to you. 
[Interview 14]
If I have a problem with my diabetes I would prefer to speak 
to someone direct and I’m not sure that by downloading or 
passing emails or sharing my information by computer to 
another health department, I don’t think, in my opinion, that 
it would be of any benefit to me. I want to be able to pick 
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up the phone and say “I’ve got real problems with my sugar 
levels and I’ve tried everything – what can you do to help.” 
I want to be able to discuss it immediately. [Interview 1]
need for face-to-face consultations
Linked to the wish for “real time” information, respondents 
talked about the need for face-to-face interaction between 
themselves and their health professionals, in order to solve 
problems, and check out and explain advice. The majority 
of respondents considered that the management of their 
diabetes would be best served by face-to-face consultations 
rather than via telehealth:
I do think that you need certain contact [with health profes-
sionals] because certainly, thinking about situations I’ve 
been in, when people have seen me, they’ve understood 
exactly how bad things are. But if you are discussing results 
all the time over the Internet or by telephone, you know, 
people don’t necessarily understand what you are physically 
going through. I do understand from information I’ve read 
and stuff, that sometimes people say that they are managing 
their diabetes when in fact they are not. And, you know, if 
you are just passing information via the Internet like that, 
nobody’s really got a handle on what’s going on. But when 
you physically see people and talk to them, you know when 
they understand things and when they don’t. I still think it’s 
very important. [Interview 30]
I think face-to-face communication is really important. If 
you are just dealing with information you could send it in 
the post. You need to receive some interaction and for him to 
say to you, “Have you tried this?” And you say, “I have, but 
I have had a problem.” And then he says, “Ah, well we can 
get around that by doing this.” To me, I would imagine that 
any problem you had would take a lot longer to resolve [with 
telehealth] because you would be battling requests regularly 
through the technology, rather than something that could be 
resolved in about five minutes face-to-face. [Interview 2]
It [telehealth] would be useful but I could see problems with 
it. If it was going to be, you know, like on the basis of just 
sending blood sugar results. There are lots of other things 
that come into diabetes care that if you are talking to the 
specialist nurse, and something would come up and you’d 
say, “Is that why that happened?”, or “Should I have done 
this?” I think you are better facing someone to discuss these 
things. [Interview 23]
Respondents in this study demonstrated a need to remain in 
control of the management of their diabetes as well as the belief 
they had a unique understanding of their own  disease, and 
indicated that whilst the use of technology held some utility, 
it would need to be used in a way that would provide effective 
support. They suggested that there were a number of potential 
limitations to the implementation of telehealth in relation to 
the management of their disease including, IT incompatibility, 
a lack of knowledge amongst health professionals, and a need 
to have face-to-face consultations.
Discussion
Farmer et al7 suggest that care of patients with diabetes pro-
vides an exemplar for the management of people with chronic 
disease. Current clinical pathways for supporting patients 
with diabetes involve either frequent visits to  clinics; or rou-
tine visits supplemented by telephone support, to exchange 
information about blood glucose results, and to provide advice 
on adjusting treatment.16 These are time consuming, and the 
integration of primary and secondary care management, 
the encouragement of self-management, and the systematic 
monitoring of measures of disease progression and control, 
are complex issues that may lead to problems that are difficult 
to resolve.7 There is the potential for telehealth to solve such 
problems and, indeed, use of telehealth is considered to have 
the potential to revolutionize health care provision.17 This is 
premised on the idea that teleheath will improve the efficiency 
of services, by enabling faster access to community health 
professionals and support for chronic disease management.
However, although there have been many trials of tele-
health in the UK, such services typically fail to become part 
of routine health care delivery,18 particularly for long term 
diabetes control.8,10
Mort et al19 argue that although patients have been char-
acterized in policy documents as being informed, responsible, 
and capable of being wirelessly linked to services, they have 
been silent in the design and development of telehealth 
systems. They suggest that the absence of the patient from 
the process of producing knowledge about the patient who 
receives telehealth, restricts the possibility of achieving 
workability in practice.19
The findings of this study provide valuable insights 
into perceptions of patients with type 1 diabetics about 
the potential value and problems associated with the use 
of telehealth to support the management of their disease. 
Although respondents appeared to meet the requirements 
of chronic disease patients (characterized in policy docu-
ments) as suitable for telehealth services, ie, experts in the 
management of their disease, employing self-care, and tech-
nologically connected,3 they identified a range of problems 






they perceived as a barrier to their use of telehealth. Three 
main issues emerged:
Firstly, they expressed a need to remain in control of 
their disease management and considered that telehealth 
could alter the power relations/balance between themselves 
and their health professionals. This in turn, they felt, had 
the potential to undermine the management of their disease, 
because they considered some health professionals to be less 
knowledgeable than they were about the disease.
Secondly, even though the majority of respondents were 
able to use technology to facilitate the management of their 
disease, they identified a number of factors that acted as 
barriers including, the lack of compatibility of IT systems, 
lack of NHS staff time, and an inability of the NHS to 
deliver real time support. Given the customized nature of the 
insulin pumps and blood glucose meters used by diabetics, 
connectivity presents a challenge for the NHS.
Thirdly, they considered that face-to-face consultation 
was of key importance in supporting them to manage their 
disease appropriately and that only within this context, could 
they receive quality care.
The engagement of patients in the coproduction of 
knowledge about the design and implementation of tele-
health has been absent, having been, according to Mort 
et al,19 ghettoized within the legitimizing device of the 
patient satisfaction survey. Thus although patients may 
be supportive of telehealth, this is not the same as having 
views about how it may be effectively implemented in rela-
tion to their own chronic disease, and such views would 
need to be taken into consideration to achieve successful 
implementation.
Respondents in this study had been self-managing their 
complex disease for many years and most received care from 
a diabetes specialist, and as such, they provide an ideal group 
to explore issues around the implementation of telehealth. 
However, the findings may not be as relevant for people with 
type 2 diabetes as this does not necessarily require the same 
degree of self-management as type 1 diabetes.
Conclusion
Although telehealth is considered to be revolutionizing 
health care delivery and shifting power relationships between 
patients and health professionals, evidence of its effective-
ness in delivering improved outcomes for the provision of 
diabetes services is limited. The findings of the study reported 
in this paper suggest that if teleheath is to be successfully 
implemented, better understanding of the context of diabetes 
self-management, and of patients’ perceptions of the role 
they would play in services delivered using telehealth, is 
needed. The interesting and important findings of this study 
are firstly, that respondents reported an inability to share 
their patient generated electronic data with NHS systems; 
secondly, that NHS health care professionals were not gener-
ally interested in such data, did not know how to use it, did 
not have the time to use it, and did not trust it; and thirdly, 
that respondents believed face-to-face consultations were 
necessary for the care of type 1 diabetes. All three barriers 
could form barriers to telehealth in the management of type 
1 diabetes, especially in the context of newly introduced 
technology such as continuous subcutaneous insulin infusion 
or insulin pumps.
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